Chemical genetic screens for TDP-43 modifiers and amyotrophic lateral sclerosis therapeutics

Principal Investigator: Pierre Drapeau
Theme : Health
Competition : Pilot projects GQ
Status : Completed
Start : Oct. 1, 2010
End: Sept. 30, 2012
Budget : $190,476.00

Pierre Drapeau and his team at Université of Montréal have recently discovered mutations in the gene (TDP-43) associated with amyotrophic lateral sclerosis (ALS). The team will use zebrafish, a model system for the study of neuromotor diseases. Because the embryos are small, they can be obtained in large numbers and develop motor behaviors within a day; it is possible to screen thousands of compounds to restore motricity.

By using this innovative model, Professor Drapeau’s team will try to develop new ALS therapeutics approaches, a disease for which no effective treatment is available.



Edor Kabashi Université de Montréal